These findings suggest that melatonin might exacerbate the phenotype in the SOD1G93A mouse ALS model due to the upregulation of toxic human SOD1, which may override its antioxidant and anti-apoptotic effects [392]. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.